Sapat Global Health Profile
Key Indicators
- Authorised Capital ₹ 1.25 Cr
as on 24-10-2024
- Paid Up Capital ₹ 1.02 Cr
as on 24-10-2024
- Company Age 30 Year, 2 Days
- Last Filing with ROC 31 Mar 2023
- Revenue -16.49%
(FY 2023)
- Profit -89.06%
(FY 2023)
- Ebitda -102.53%
(FY 2023)
- Net Worth 1.59%
(FY 2023)
- Total Assets -16.30%
(FY 2023)
About Sapat Global Health
The Corporate was formerly known as Sapat And Company (Bombay) Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.25 Cr and a paid-up capital of Rs 1.02 Cr, as per Ministry of Corporate Affairs (MCA) records.
Nikhil Joshi and Ritu Joshi serve as directors at the Company.
- CIN/LLPIN
U24230MH1995PTC084552
- Company No.
084552
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Jan 1995
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Sapat Global Health Private Limited offer?
Sapat Global Health Private Limited offers a wide range of products and services, including Common Disease Medicines, Skin Ointment.
Who are the key members and board of directors at Sapat Global Health?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nikhil Joshi  | Managing Director | 29-Jan-2000 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ritu Joshi | Director | 18-May-2018 | Current |
Financial Performance of Sapat Global Health.
Sapat Global Health Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 16.49% decrease. The company also saw a substantial fall in profitability, with a 89.06% decrease in profit. The company's net worth moved up by a moderate rise of 1.59%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sapat Global Health?
In 2023, Sapat Global Health had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sapat Global Health?
Sapat Global Health has a workforce of 140 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sapat Global Health, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sapat Global Health's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
